Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2011
05/05/2011US20110104143 Treating Basal-Like Genotype Cancers
05/05/2011US20110104136 Natural Killer p30 (NKp30) Dysfunction and the Biological Applications Thereof
05/05/2011US20110104129 T cell receptors and related materials and methods of use
05/05/2011US20110104075 129Xe BIOSENSORS AND THEIR USE
05/05/2011US20110104070 Site specific fluorescence and contrast marker for same
05/05/2011US20110104064 Cyclized non-native synthetic peptide and complex of peptides comprising said cyclized peptide, intended to induce and to characterize the prevention or treatment of conditions in mammals
05/05/2011US20110104062 Biomarkers for Head-And-Neck Cancers and Precancers
05/05/2011US20110104059 Membrane Associated Tumor Endothelium Markers
05/05/2011US20110104053 HUMAN IgM ANTIBODIES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF PARTICULARLY IN THE CENTRAL NERVOUS SYSTEM
05/05/2011US20110104050 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
05/05/2011US20110104010 Binding reagent system for homogeneous immunoassays for multiple allergens
05/05/2011US20110104009 Clinical examination disk, disk pack, and clinical examination device
05/05/2011US20110104007 Automatic analyzing device
05/05/2011US20110102769 Small angle light scattering assay system and method for detecting malaria infection
05/05/2011US20110102768 Method of determining glucose concentration of a whole blood sample
05/05/2011US20110102182 Alcohol concentration detecting device
05/05/2011US20110102177 Diver Monitoring and Communication System
05/05/2011US20110100210 Diagnosis of the operability of fuel vapour intermediate stores
05/05/2011US20110100092 Method of determining the fuel content in a combustion engine lubricating oil
05/05/2011US20110100088 Articles Of Manufacture Containing Increased Stability Low Concentration Gases And Methods Of Making And Using The Same
05/05/2011DE202011002870U1 Untersatz für Objektträger zur Forschung der Thrombozytenaggregation Trays for slides to the research of platelet aggregation
05/05/2011DE202011002869U1 Haltevorrichtung für Objektträger für die Auswertung einer Thrombozytenaggregation Holding device for microscope slides for evaluation of a platelet aggregation
05/05/2011DE202011002867U1 Untersatz für Flaschen mit Induktoren einer Thrombozytenaggregation, für Pipetten und Glasstäbe Trays for bottles with inducers of platelet aggregation, for pipettes and glass rods
05/05/2011DE202011001747U1 Einrichtung zur qualitativen und/oder quantitativen Erfassung von Quecksilberemmissionen Device for the qualitative and / or quantitative detection of mercury emissions
05/05/2011DE202010016519U1 Steckverbindung und Biosensormessgerät mit Steckverbindung Connector and Biosensormessgerät with connector
05/05/2011DE202010004193U1 Testbestecks zur Bestimmung von neuroregulatorischen und psychischen Störungen Test kit for the determination of neuromodulatory and mental disorders
05/05/2011DE102010023523A1 Method for integrative measurement of quantity of e.g. components, in exhaust gas mixture in motor vehicle, involves loading gas components in storage material, and changing and measuring physical parameter of material
05/05/2011DE102009051428A1 Reagenzienpatrone für eine Anordnung zur wahlweisen Durchführung eines klinisch-chemischen Tests oder eines ELISA-Tests Reagent cartridge for an arrangement for selectively performing a clinical chemistry test or ELISA
05/05/2011DE102009046075A1 Verfahren zum Bestimmen des Anteils an schweren Dieselbestandteilen in einem verdünnten Motoröl A method for determining the proportion of heavy parts same status in a dilute engine oil
05/05/2011DE102009040881A1 Verfahren zur Bestimmung der Thrombozytenfunktion mit einem Resonator Process for the determination of platelet function with a resonator
05/05/2011DE102007039798B4 Vorrichtung zur Feldflußfraktionierung Device for Field-Flow Fractionation
05/05/2011CA2814449A1 Composition, device and method for colorimetric detection of an analyte using imprinted polymers and photochromic switch molecules
05/05/2011CA2779484A1 A melanoma prognostic model using tissue microarrays and genetic algorithms
05/05/2011CA2779306A1 Analyte quantification multiplex microarrays combining internal and external calibration
05/05/2011CA2779270A1 Method of predicting risk of preterm birth
05/05/2011CA2779191A1 Method for assaying component to be assayed in specimen and assay kit
05/05/2011CA2779144A1 Multipotent stem cells from the extrahepatic biliary tree and methods of isolating same
05/05/2011CA2779099A1 Templated nanoconjugates
05/05/2011CA2778540A1 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection
05/05/2011CA2778539A1 Methods for diagnosing irritable bowel syndrome
05/05/2011CA2777900A1 A system for testing cement
05/05/2011CA2777705A1 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
05/05/2011CA2777695A1 Pcsk9 immunoassay
05/05/2011CA2777365A1 Method for producing implantable medical bioprlstheses having reduced calcifiation properties
05/05/2011CA2775903A1 Podxl protein in colorectal cancer
05/05/2011CA2774919A1 Dosage regimen for administering a cd19xcd3 bispecific antibody
05/05/2011CA2774467A1 Combustible gas sensors including integral support structures and combustible gas sensor with multiple active elements
05/05/2011CA2774452A1 Electrochemical sensors including electrodes with diffusion barriers
05/05/2011CA2774286A1 Use of immunoregulatory nk cell populations for predicting the efficacy of anti-il-2r antibodies in multiple sclerosis patients
05/04/2011EP2317325A1 5-fluoro-uracil immunoassay
05/04/2011EP2317324A1 Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
05/04/2011EP2317323A1 MALDI Mass Spectrometry (MALDI-MS) for proteins of high molecular weight
05/04/2011EP2317321A1 Methods for monitoring Alzheimer's progression by measuring a biomarker
05/04/2011EP2317320A2 Polypeptide markers for the diagnosis of prostate cancer
05/04/2011EP2317319A1 Porous solid phase for binding assay, and binding assay method using the same
05/04/2011EP2317318A1 Fragments of fluorescent proteins for protein fragment complementation assays
05/04/2011EP2317317A1 Prion protein ligands and methods of use
05/04/2011EP2317316A2 Methods for identifying agent and conditions that modulate neurogenesis
05/04/2011EP2317314A1 Sensors
05/04/2011EP2317313A1 Test meter for use with dual chamber, multi-analyte test strip with opposing electrodes
05/04/2011EP2317312A2 Method and cell for measuring the overall concentration of ions in a bodily fluid
05/04/2011EP2317311A2 Sensing network and method
05/04/2011EP2317307A2 Method of analyzing amino- and/or imino-functional compounds, and analytical reagent
05/04/2011EP2317306A1 Sensor for biological or chemical materials and array of said sensor
05/04/2011EP2316976A1 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
05/04/2011EP2316975A1 Asynchronous primed PCR
05/04/2011EP2316969A1 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer
05/04/2011EP2316966A1 CIZ1 replication protein
05/04/2011EP2316959A2 Transgenic non-human animals for pharmacological and toxicological studies
05/04/2011EP2316939A2 Novel peptide
05/04/2011EP2316936A1 Method for analysis/identification of antibody gene at one-cell level
05/04/2011EP2316935A1 Aptamer against il-17 and use thereof
05/04/2011EP2316931A1 Polymer-coupled peptidases
05/04/2011EP2316925A1 Circovirus sequences associated with porcine wasting disease (PWD)
05/04/2011EP2316857A1 Monoclonal antibodies that specifically bind to folate receptor alpha
05/04/2011EP2316855A1 Antihuman Alpha-9 integrin antibody and use of the same
05/04/2011EP2316854A1 Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin D metabolite.
05/04/2011EP2316852A1 Stabilized single domain antibodies
05/04/2011EP2316844A2 Peptide complex
05/04/2011EP2316843A1 Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma
05/04/2011EP2316487A1 Recombinant IL-9 antibodies & uses thereof
05/04/2011EP2316486A2 Cripto blocking antibodies and uses thereof
05/04/2011EP2316481A1 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection
05/04/2011EP2316480A1 Chimeric tymovirus-like particles
05/04/2011EP2316474A1 Pregnancy-related enzyme PC 5/6 antagonists
05/04/2011EP2316276A2 Genes encoding proteolytic enzymes from aspargilli
05/04/2011EP2316038A2 Methods for removal of specific seed tissue or structure for seed analysis
05/04/2011EP2316037A2 Apparatus for removal of specific seed tissue or structure for seed analysis
05/04/2011EP2316036A2 Stimulated cell standards
05/04/2011EP2316035A2 Thrombin substrate and assay for determining the level of bioactive thrombin in a sample
05/04/2011EP2316034A1 Multiplexed diagnostic test for preterm labor
05/04/2011EP2316033A2 Detection of prostate cancer using psa glycosylation patterns
05/04/2011EP2316032A1 Methods for predicting the response to anti-cancer treatment with an agonist of tlr7 or an agonist of tlr8
05/04/2011EP2316031A2 Il-8 biomarker for monitoring cancer treatment.
05/04/2011EP2316030A2 Protein screeing methods
05/04/2011EP2316029A1 Sample carrier for effecting chemical assays
05/04/2011EP2316028A1 A method of evaluating the integrity of the plasma membrane of cells by detecting glycans found only intracellularly
05/04/2011EP2316027A2 Calibration surface method for determination of analyte ratios
05/04/2011EP2316026A1 Method of determination of receptor binding saturation effected by monoclonal antibodies
05/04/2011EP2316025A1 Means for the detection and treatment of prostate cells